Chemotherapy Biotherapy Certification ONS Practice Testq

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ONS Chemotherapy Biotherapy Certification Exam. Leverage flashcards and multiple choice questions, complete with hints and explanations. Equip yourself for exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What mechanism do anti-tumor antibiotics use during chemotherapy?

  1. Inhibit RNA synthesis

  2. Interfere with nucleic acid duplication

  3. Block enzymes necessary for DNA synthesis

  4. Alter cellular oxygen levels

The correct answer is: Interfere with nucleic acid duplication

Anti-tumor antibiotics primarily exert their effects by interfering with nucleic acid duplication. These agents, such as doxorubicin and bleomycin, bind to DNA and disrupt the process of replication and transcription. This interaction ultimately prevents cancer cells from replicating their DNA, leading to cellular death. The other options provided do describe various mechanisms of action for different classes of chemotherapy drugs, but they do not accurately reflect the primary mechanism employed by anti-tumor antibiotics. Inhibition of RNA synthesis is more characteristic of certain other types of chemotherapeutic agents or antiviral drugs. Blocking enzymes necessary for DNA synthesis typically refers to drugs that target specific enzymes involved in the DNA replication process, such as topoisomerase inhibitors or antimetabolites. Altering cellular oxygen levels is not a mechanism employed by anti-tumor antibiotics; rather, it can be a broader concept in cancer biology relating to tumor microenvironments. Therefore, the accurate choice highlights how anti-tumor antibiotics specifically disrupt the duplication of nucleic acids to hinder tumor growth.